HQY Company Profile and Key Details

Q: Who are the executives of HQY?

Mr. Jon KesslerPres, Chief Executive Officer & DirectorMs. Angelique Christine HillExecutive Vice President of OperationsMr. Brad BennionSenior Vice President of Corporation Devel.Mr. Steve LindsayExecutive Vice President of Sales & Relationship ManagementMr. Elimelech RosnerExecutive Vice President & Chief Technology OfficerMr. Larry L. TrittschuhExecutive Vice President & Chief Security OfficerMs. Tia PadiaExecutive Vice President & Chief Marketing OfficerMr. Tyson MurdockExecutive Vice President & Chief Financial OfficerMr. Darcy G. MottSpecial AdvisorDr. Stephen D. NeelemanFounder & Vice ChairmanMr. Richard PutnamVice President of Investor RelationsMr. Delano LaddExecutive Vice President, Gen. Counsel & Sec.Cheryl KingExecutive Vice President & Chief People Officer

NASDAQ : HQY

HealthEquity

$82.10

0.46+0.56%

At Close 4:00 PM

71.24

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

HealthEquity, Inc. (HQY) stock surged +0.56%, trading at $82.10 on NASDAQ, up from the previous close of $81.64. The stock opened at $81.20, fluctuating between $80.39 and $82.27 in the recent session.

Stock Snapshot

81.64

Prev. Close

7.01B

Market Cap

80.39

Day Low

33.37

P/E Ratio

2.46

EPS (TTM)

2.29

Cash Flow per Share

81.2

Open

85.44M

Number of Shares

82.2675

Day High

97.43%

Free Float in %

23.67

Book Value

773.74K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 24, 2026	81.20	82.27	80.39	82.10	773.6K
Mar 23, 2026	81.77	82.46	80.21	81.64	771.53K
Mar 20, 2026	81.06	82.03	79.79	81.02	1.3M
Mar 19, 2026	79.91	82.50	79.86	81.13	921.15K
Mar 18, 2026	79.40	83.37	77.72	79.57	1.84M
Mar 17, 2026	79.61	80.88	78.90	79.40	1.26M
Mar 16, 2026	78.02	79.63	78.02	78.67	1.1M
Mar 13, 2026	76.86	77.85	75.31	77.81	1.16M
Mar 12, 2026	77.39	78.47	76.68	76.79	818.05K
Mar 11, 2026	78.26	78.98	77.45	78.57	535.99K
Mar 10, 2026	78.92	81.55	77.00	78.50	674.75K
Mar 09, 2026	78.23	80.58	77.46	80.04	692.73K
Mar 06, 2026	79.14	79.59	75.00	78.36	1.38M
Mar 03, 2026	76.66	81.61	76.31	80.43	917.42K
Mar 02, 2026	75.38	78.09	75.17	77.93	709.67K
Feb 27, 2026	76.07	77.02	74.96	76.49	711.39K
Feb 26, 2026	75.95	78.15	75.52	77.39	620.02K
Feb 25, 2026	76.30	76.67	74.87	75.56	860.24K
Feb 24, 2026	75.95	77.61	74.01	75.89	627.78K
Feb 23, 2026	77.94	78.39	75.56	75.87	955.5K

Contact Details

Draper, UT 84020

United States

https://www.healthequity.com 801 727 1000

About Company

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Stock Peers

BTSGU

3.835+2.72%

BrightSpring Health Services, Inc. Tangible Equity Unit$144.79 NUTX

4.51+4.75%

Nutex Health, Inc.$99.49 GEHC

-0.69-0.96%

GE HealthCare Technologies Inc.$70.96 WGS

-3.47-4.81%

GeneDx Holdings Corp.$68.67 TEM

-0.31-0.63%

Tempus AI, Inc.$48.83 BTSG

1.21+2.87%

BrightSpring Health Services, Inc. Common Stock$43.31 OMCL

0.15+0.44%

Omnicell, Inc.$34.46 PINC

0.09+0.32%

Premier, Inc.$28.26 HTFL

1.15+4.29%

Heartflow, Inc. Common Stock$27.97 CCLDO

CareCloud, Inc.$26.18

Company Overview

HealthEquity, Inc. (NASDAQ:HQY) closed at $82.10 USD, gaining $0.46 (0.56%) from the previous close of $81.64. The stock is currently mid-range between its 52-week high and low $72.76 and $116.65. With a market capitalization of about $7.01 billion, HealthEquity, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.32). Key stats such as the average daily volume over the past year has been around 1.00 million shares, in line with its 52-week average. Headquartered in Draper, UT, HealthEquity, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Scott R. Cutler, the company employs approximately 3,105 people and listed since July 31, 2014. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.

Technical Performance

HQY has shown mixed momentum, losing -0.66% over the past week and -8.16% over the past quarter, though year-to-date performance is down -8.31%. Short-term trend indicators are bullishly aligned (SMA20 -1.67%, SMA50 -9.78%, SMA200 -17.69%). The stock’s 14-day RSI is 42.32 (neutral), while the ATR of 2.95 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -33.66% below its high and over 6.36% above its low. Average 10-day trading volume of 1.14 million shares is slightly above the 3-month average of 981.73 thousand, indicating heightened recent market interest.

Valuation Metrics

HealthEquity, Inc. trades at a P/E ratio of 32.82, slightly above the S&P 500 average, with a price-to-sales ratio of 5.33 and a price-to-book ratio of 3.35 trading at moderately above to book value. The P/FCF stands at 15.95, also below market averages.

Dividend & Fair Value

HealthEquity, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $224.47. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

HealthEquity, Inc. generated EPS of $2.18 over the past year. Five-year average earnings growth is 13.44%. Wall Street analysts project EPS growth of 20.1% annually over the next five years. The latest quarter delivered EPS of $0.59. The next quarter is forecast at $0.90. Next year's EPS is expected at $31.40. Analyst sentiment is bullish. Analyst rating data shows there are 20 Strong Buy ratings, 5 Buy ratings, 3 Hold ratings, 1 Sell rating and 0 Strong Sell ratings. Price targets range from $134.00 to $89.00. The high target offers 63.22% upside. The low target suggests 8.4% downside. The mean target is $116.93. This offers 42.42% upside. HealthEquity, Inc. earnings surprise history is a mixed track record. The quarter that ended December 03, 2025, missed forecasts by -34.0%. The prior quarter beat by 18.16%. Over the last six quarters, Apple has recorded several small beats. These include -42.27% in September 03, 2024.

Shareholding & Insider Activity

HealthEquity, Inc. has 86.48 million shares outstanding. The public float is 84.86 million shares, elevated short interest at 6.81% of float. This equals 5.09 million shares. The short ratio is 5.87 days. Institutional investors hold 110.9% of the float. Insiders own 2.19%. Sacks Ian holds 109.63 thousand shares, MOTT DARCY G has 91.05 thousand shares and Neeleman Stephen has 89.77 thousand shares. Over the past six months, insider transactions show net selling. They sold 21.58 thousand shares across 6 transactions.

Financial & Profitability Overview

Over the trailing twelve months, HealthEquity generated $1.31B in revenue, or $15.02 per share. Gross margin was 69.52%, operating margin 24.55%, and net profit margin 16.38%. Returns are healthy, with ROA at 6.27% and ROE at 10.21%.
On valuation metrics, HealthEquity trades at a P/E of 32.82, P/S of 5.33 and P/B of 3.35. The current ratio is 3.27 and quick ratio is 3.27. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 23.29 days. Debt-to-equity is 0.48, supported by a cash flow-to-debt ratio of 0.46.

Quarterly Financial Highlights

For the quarter ended Jan 31, 2026, HealthEquity posted revenue of $1.31B, down slightly from $1.20B in the prior quarter. Gross profit was $913.12M (margin 69.52%). Operating income was $322.46M (margin 24.6%). Net income was$215.20M (EPS $2.50).
The company ended the quarter with $318.93M in cash and short-term investments, a total debt of $1.00B, and net debt of $682.55M. Total assets were $3.43B, with equity of $2.11B. Financials further reflected stability, with operating cash flow of $457.09M, free cash flow of $455.13M, and capital expenditures of - $1.97M.

Price Forecast & Outlook

Our AI price prediction model suggests that HealthEquity, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.71%, with price expected at $83.50 by April 06, 2026, within a range of $81.30 to $85.64 3-Month Outlook: Projected rise of 28.42%, reaching $105.43 by June 19, 2026, with a range of $101.69 to $109.58. 1-Year Outlook: Projected gain of 14.79%, with price at $94.24 by March 23, 2027, within a range of $91.07 to $97.85.

Key Takeaways

HealthEquity, Inc. (NASDAQ:HQY) shares are flat -8.31% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows HealthEquity, Inc. trading at a premium to the broader market with a P/E of 32.82. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $98.42, suggesting 19.88% upside. Our AI forecast model points to short-term strength (1.71% over two weeks), a medium-term rise (28.42% over three months), and a longer-term gain (14.79% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current HealthEquity, Inc. (HQY) stock price?

HealthEquity, Inc. (NASDAQ: HQY) stock price is $82.10 in the last trading session. During the trading session, HQY stock reached the peak price of $82.27 while $80.39 was the lowest point it dropped to. The percentage change in HQY stock occurred in the recent session was 0.56% while the dollar amount for the price change in HQY stock was $0.46.

HQY's industry and sector of operation?

The NASDAQ listed HQY is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. HealthEquity, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HQY?

Mr. Jon Kessler
Pres, Chief Executive Officer & Director
Ms. Angelique Christine Hill
Executive Vice President of Operations
Mr. Brad Bennion
Senior Vice President of Corporation Devel.
Mr. Steve Lindsay
Executive Vice President of Sales & Relationship Management
Mr. Elimelech Rosner
Executive Vice President & Chief Technology Officer
Mr. Larry L. Trittschuh
Executive Vice President & Chief Security Officer
Ms. Tia Padia
Executive Vice President & Chief Marketing Officer
Mr. Tyson Murdock
Executive Vice President & Chief Financial Officer
Mr. Darcy G. Mott
Special Advisor
Dr. Stephen D. Neeleman
Founder & Vice Chairman
Mr. Richard Putnam
Vice President of Investor Relations
Mr. Delano Ladd
Executive Vice President, Gen. Counsel & Sec.
Cheryl King
Executive Vice President & Chief People Officer

How HQY did perform over past 52-week?

HQY's closing price is 12.84% higher than its 52-week low of $72.76 where as its distance from 52-week high of $116.65 is -29.62%.

How many employees does HQY have?

Number of HQY employees currently stands at 3,105.

Link for HQY official website?

Official Website of HQY is: https://www.healthequity.com

How do I contact HQY?

HQY could be contacted at phone 801 727 1000 and can also be accessed through its website. HQY operates from 15 West Scenic Pointe Drive, Draper, UT 84020, United States.

How many shares of HQY are traded daily?

HQY stock volume for the day was 773.74K shares. The average number of HQY shares traded daily for last 3 months was 1M.

What is the market cap of HQY currently?

The market value of HQY currently stands at $7.01B with its latest stock price at $82.10 and 85.44M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	3105
Beta	0.26
Sales or Revenue	$1.31B
5Y Sales Change%	0.543%
Fiscal Year Ends	January
Sector	Healthcare
Industry	Medical - Healthcare Information Services

HQY Company Profile and Key Details

HealthEquity

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Shareholding & Insider Activity

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook